Dermata Therapeutics, Inc. (DRMA)
0.8699
+0.01
(+1.16%)
USD |
NASDAQ |
Oct 20, 16:00
0.85
-0.02
(-2.29%)
After-Hours: 05:45
Dermata Therapeutics Max Drawdown (5Y) : 99.99% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.99% |
| August 31, 2026 | 99.99% |
| July 31, 2026 | 99.99% |
| June 30, 2026 | 99.99% |
| May 31, 2026 | 99.99% |
| April 30, 2026 | 99.99% |
| March 31, 2026 | 99.99% |
| Date | Value |
|---|---|
| February 28, 2026 | 99.99% |
| January 31, 2026 | 99.99% |
| December 31, 2025 | 99.99% |
| November 30, 2025 | 99.99% |
| October 31, 2025 | 99.98% |
| September 30, 2025 | 99.97% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Anika Therapeutics, Inc. | 83.15% |
| Perspective Therapeutics, Inc. | 93.08% |
| MiMedx Group, Inc. | 85.36% |
| ABVC BioPharma, Inc. | 99.79% |
| Agilent Technologies, Inc. | 43.19% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -94.49 |
| Beta (5Y) | 0.6613 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 82.97% |
| Historical Sharpe Ratio (5Y) | -1.059 |
| Historical Sortino (5Y) | -1.570 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 47.32% |